From the Department of Clinical Neurosciences (J.I.R., A.K.);Department of Pediatrics (K.W., A.K., M.J.E.), Cumming School of Medicine, University of Calgary; Alberta Children's Hospital Research Institute (A.K., M.J.E.), University of Calgary; Hotchkiss Brain Institute (A.K., M.J.E.), University of Calgary, Alberta, Canada.
Neurology. 2022 Feb 15;98(7):292-295. doi: 10.1212/WNL.0000000000013181. Epub 2021 Dec 8.
Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant condition that is linked to a myriad of neurologic complications arising from vascular malformations of the brain, spinal cord, and lungs. Our case describes a previously healthy 3-year-old male who presented to hospital with fever of unknown origin and was found to have a brain abscess stemming from a pulmonary arteriovenous malformation (PAVM). This etiology was identified after a period of diagnostic delay; the medical team was suspicious for a proximal embolic source due to the presence of multiple tiny infarcts seen on MRI of the brain, but transthoracic echocardiogram and head and neck angiogram were unremarkable. Fortunately, an enhanced CT of the chest was performed, identifying a moderately sized PAVM. PAVMs are associated with intracranial abscesses due to shunting and loss of the normal filtering effects of the lung capillary bed. Impaired pulmonary filtration can permit paradoxical thromboemboli and septic microemboli to enter systemic circulation, predisposing patients with PAVMs to cerebral abscess and ischemic stroke. Screening for PAVMs with contrast-enhanced echocardiogram or enhanced CT of the chest may be considered in patients with cryptogenic brain abscess or recurrent embolic stroke of unknown origin. PAVMs are often associated with hereditary hemorrhagic telangiectasia (HHT). As many features of HHT have delayed clinical manifestation, genetic testing for HHT should be considered in all people with PAVM, even in the absence of other clinical features. In our case, genetic testing returned positive, confirming a new diagnosis of HHT type 1.
遗传性出血性毛细血管扩张症(HHT)是一种常染色体显性遗传疾病,与脑、脊髓和肺部血管畸形引起的多种神经系统并发症有关。我们的病例描述了一位之前健康的 3 岁男性,因不明原因发热就诊,被发现患有源自肺动静脉畸形(PAVM)的脑脓肿。经过一段时间的诊断延迟,确定了这种病因;由于脑部磁共振成像显示存在多个微小梗死灶,医疗团队怀疑存在近端栓塞源,但经胸超声心动图和头颈部血管造影未见异常。幸运的是,进行了增强胸部 CT 检查,发现一个中等大小的 PAVM。由于分流和肺毛细血管床正常滤过作用的丧失,PAVM 与颅内脓肿有关。肺滤过功能受损可使反常血栓栓子和感染性微栓子进入体循环,使 PAVM 患者易患脑脓肿和缺血性中风。对于隐源性脑脓肿或原因不明的复发性栓塞性中风患者,可考虑使用增强超声心动图或增强胸部 CT 筛查 PAVM。PAVM 常与遗传性出血性毛细血管扩张症(HHT)有关。由于 HHT 的许多特征具有延迟的临床表现,因此即使没有其他临床特征,也应考虑对所有 PAVM 患者进行 HHT 基因检测。在我们的病例中,基因检测结果为阳性,确诊为 1 型 HHT。